All Stories

  1. Ictal and Interictal Language Impairment in RBFOX1-Related Neurodevelopmental Disorder
  2. Epilepsy in refugee camps in Algeria: clinical characteristics, treatment gaps, and environmental challenges in a low–resource setting
  3. Electroclinical features of epilepsy in AUTS2-related syndrome: case description and narrative review
  4. Cardiac autonomic dysfunction in pediatric-onset epilepsy: insights from heart rate variability analysis
  5. ATP1A3 : Uncommon and wavering epilepsy phenotype in a rare variant
  6. Enlarging the phenotypical spectrum of DYNC1H1-related epilepsy
  7. Do Cenobamate Pharmacokinetics Change with Co-Administered Antiseizure Medications? An Exploratory Analysis of Responder Patients with Focal Drug-Resistant Epilepsy
  8. Effectiveness and safety of dual antiplatelet therapy in patients with minor ischemic stroke or transient ischemic attack and cancer: A secondary analysis of the READAPT study
  9. Health conditions and social problems in children and adolescents with epilepsy: The role of quality of life by employing the PedsQL-EM
  10. Clinical and genetic landscape of epilepsies with absence seizures and single‐gene etiology
  11. Safety and efficacy of rotigotine in patients with frontotemporal dementia: a phase 2, double-blind, randomized, placebo-controlled, multicenter trial
  12. Changes in Gray Matter Morphology and White Matter Microstructure Across the Adult Lifespan in People With Temporal Lobe Epilepsy
  13. Clinical predictors and concomitant antiseizure medications effects on seizure control in relation to plasma cenobamate concentration: a multicenter retrospective study
  14. Characteristics and causes of recurrent ischemic events in minor ischemic stroke and TIA in the READAPT study
  15. Neuroimaging Features of GRIN-Related Epilepsies
  16. Neuroglial biomarkers in autoimmune encephalitis: advances in diagnosis, prognosis, and pathophysiological insights
  17. Molecular and clinical spectrum of epilepsy-dyskinesia syndromes: a cross-sectional study of 609 patients
  18. Real-world outcomes following dual antiplatelet therapy in mild-to-moderate ischemic stroke with anterior versus posterior circulation infarct: a READAPT study propensity matched analysis
  19. Rasmussen encephalitis and localized scleroderma of the lower limb: Another piece of the puzzle. A case-report and literature review with individual participant data
  20. Dynamic electro‐clinical features in Guanidinoacetate N‐methyltransferase deficiency: A familial case series
  21. Effectiveness of perampanel as only concomitant antiseizure medication for highly active epilepsy: insight from a real-world, multicenter retrospective study
  22. A Novel Epilepsy Phenotype in a Young Girl With a Pathogenic SETD5 Gene Variant
  23. Cerebral Palsy in a Rural Desert Population of Southern Algeria: A Cross-Sectional Study of Epidemiology of Comorbidities and Unmet Needs
  24. EEG microstates during resting-state and dissociative events in patients with psychogenic non-epileptic seizures
  25. Admission systolic blood pressure and short-term outcomes after dual antiplatelet therapy in patients with minor ischemic stroke or transient ischemic attack
  26. Real‐World Dual Antiplatelet Therapy Use Exceeds Randomized Trials Boundaries With Possible Safety Issues in Patients With Large Artery Atherosclerosis—Insights From the READAPT Study
  27. Self‐Esteem and Psychopathology Differentially Relate to Real‐Life and Social Functioning in People With 22q11.2 Deletion Syndrome
  28. Expanding the therapeutic role of highly purified cannabidiol in monogenic epilepsies: A multicenter real‐world study
  29. Medication‐resistant epilepsy is associated with a unique gut microbiota signature
  30. Adjunctive Brivaracetam in People with Epilepsy and Intellectual Disability: Evidence from the BRIVAracetam Add-On First Italian netwoRk Study
  31. Epileptic spasms and RNA analysis in a new case of Kabuki syndrome type 2
  32. Impact of SDHA Mutations on Yeast Growth and Mitochondrial Function. Case Study Linking Genetic Findings to Clinical Phenotypes
  33. Exploring Sex Differences in Outcomes of Dual Antiplatelet Therapy for Patients With Noncardioembolic Mild-to-Moderate Ischemic Stroke or High-Risk Transient Ischemic Attack: A Propensity-Matched Analysis of the READAPT Study Cohort
  34. EEG Abnormalities and Phenotypic Correlates in Preschoolers with Autism Spectrum Disorder: A Single-Center Study
  35. Reconstructing whole-brain structure and dynamics using imaging data and personalized modeling
  36. Cortical Deafness in Children: Scoping Review and Case Report of a Bilateral Perinatal Stroke
  37. Phase 2 study of palmitoylethanolamide combined with luteoline in frontotemporal dementia patients
  38. Phenotypic traits and family history in patients with 22q11.2 deletion syndrome and generalized epilepsy: A multicenter case–control study
  39. Real-world comparison of dual versus single antiplatelet treatment in patients with non-cardioembolic mild-to-moderate ischemic stroke: A propensity matched analysis
  40. Transient brain ischemic symptoms and the presence of ischemic lesions at neuroimaging: Results from the READAPT study
  41. Exploring the Clinical Spectrum of HUWE1 ‐Related Neurodevelopmental Disorder: Five New Patients and Literature Review
  42. Beyond RCTs: Short-term dual antiplatelet therapy in secondary prevention of ischemic stroke and transient ischemic attack
  43. Author Response: Predictors of Seizure Recurrence in Women With Idiopathic Generalized Epilepsy Who Switch From Valproate to Another Medication
  44. Defining short-term outcomes of minor ischemic stroke due to small artery occlusion in the era of dual antiplatelet treatment: A READAPT study sub-analysis
  45. Diagnosis and Classification of Pediatric Epilepsy in Sub-Saharan Africa: A Comprehensive Review
  46. Combined generalized and focal epilepsy with reflex features in Adaptor protein complex 4-associated hereditary spastic paraplegias: A cohort observational study
  47. Combining Intravenous Thrombolysis and Dual Antiplatelet Treatment in Patients With Minor Ischemic Stroke: A Propensity Matched Analysis of the READAPT Study Cohort
  48. Long‐term outcomes and adaptive behavior in adult patients with Lennox–Gastaut syndrome
  49. Double gonosomal mosaicism as an unusual hereditary mechanism in familial GRIN2A-related disorder
  50. Clinical features and genotype–phenotype correlations in epilepsy patients with de novo DYNC1H1 variants
  51. Epilepsy phenotypes across the different age-ranges in IQSEC2-related encephalopathy: An Italian multicentre retrospective cohort study
  52. Perampanel in post-stroke epilepsy: Clinical practice data from the PERampanel as Only Concomitant antiseizure medication (PEROC) study
  53. Children and Young Adults with Epilepsy Exhibit an Interictal Autonomic Dysfunction: A Prospective Exploratory Study
  54. Depressive symptoms in children and adolescents with epilepsy and primary headache: a cross-sectional observational study
  55. Non-Specific Epileptic Activity, EEG, and Brain Imaging in Loss of Function Variants in SATB1: A New Case Report and Review of the Literature
  56. Salivary α‐Synuclein as a Candidate Biomarker of Parkinsonism in 22q11.2 Deletion Syndrome
  57. Frailty as a comprehensive health measure beyond seizure control in patients with epilepsy: A cross‐sectional study
  58. Structural brain abnormalities in Pallister-Killian syndrome: a neuroimaging study of 31 children
  59. A worldwide ENIGMA study on epilepsy-related gray and white matter compromise across the adult lifespan
  60. Children with Autism Spectrum Disorder and Abnormalities of Clinical EEG: A Qualitative Review
  61. Midline non-ictal rhythmic waveforms as possible electroencephalographic biomarkers of Smith-Klingsmore syndrome in children
  62. A Novel KCNQ2 Variant in a Patient with a Combined Tremor Syndrome
  63. Resting-state electroencephalography microstates as a marker of photosensitivity in juvenile myoclonic epilepsy
  64. Correction to: Resting-state electroencephalography microstates as a marker of photosensitivity in juvenile myoclonic epilepsy
  65. Perampanel as only add-on epilepsy treatment in elderly: A subgroup analysis of real-world data from retrospective, multicenter, observational study
  66. Correction to “Perampanel as precision therapy in rare genetic epilepsies”
  67. Adjunctive brivaracetam and sustained seizure frequency reduction in very active focal epilepsy
  68. Incidence and Long-term Functional Outcome of Neurologic Disorders in Hospitalized Patients With COVID-19 Infected With Pre-Omicron Variants
  69. The photoparoxysmal response belongs to the spectrum of electroencephalographic findings in patients with triple X syndrome and epilepsy
  70. Models of care in emergency neurology: from the Neuro Fast Track to the emergency neurologist—a position paper of the Italian Association for Emergency Neurology (ANEU)
  71. Divergence Between Clinical Trial Evidence and Actual Practice in Use of Dual Antiplatelet Therapy After Transient Ischemic Attack and Minor Stroke
  72. Clinical Course May Be Independent from Neuroimaging in DEPDC-5-Related Epilepsy
  73. Glycaemic Imbalances in Seizures and Epilepsy of Paediatric Age: A Literature Review
  74. The Central Noradrenergic System in Neurodevelopmental Disorders: Merging Experimental and Clinical Evidence
  75. Perampanel as precision therapy in rare genetic epilepsies
  76. Editorial: Advances in neuroimaging of epilepsy
  77. CUL4B-associated epilepsy: Report of a novel truncating variant promoting drug-resistant seizures and systematic review of the literature.
  78. Does 7T MRI reveal a neuronal bridge between periventricular heterotopia and overlying cortical malformations?
  79. An Italian consensus on the management of Lennox-Gastaut syndrome
  80. Tremor and Movement Slowness Are Two Unrelated Adverse Effects Induced by Valproate Intake
  81. Effectiveness of perampanel as the only add‐on: Retrospective, multicenter, observational real‐life study on epilepsy patients
  82. Brivaracetam as Early Add-On Treatment in Patients with Focal Seizures: A Retrospective, Multicenter, Real-World Study
  83. Different epilepsy course of a novel AHDC1 mutation in a female monozygotic twin pair
  84. Drug-resistant epilepsy at the age extremes: Disentangling the underlying etiology
  85. The Clinical Impact of Methotrexate-Induced Stroke-Like Neurotoxicity in Paediatric Departments: An Italian Multi-Centre Case-Series
  86. Event‐based modelling in temporal lobe epilepsy demonstrates progressive atrophy
  87. Brivaracetam as add-on treatment in patients with post-stroke epilepsy: real-world data from the BRIVAracetam add-on First Italian netwoRk Study (BRIVAFIRST)
  88. Adjunctive Brivaracetam in Older Patients with Focal Seizures: Evidence from the BRIVAracetam add‑on First Italian netwoRk Study (BRIVAFIRST)
  89. Sustained seizure freedom with adjunctive brivaracetam in patients with focal onset seizures
  90. Hyperosmolar hyperglycaemic state causing atypical status epilepticus with hippocampal involvement
  91. Topographic divergence of atypical cortical asymmetry and atrophy patterns in temporal lobe epilepsy
  92. Correction to: Adjunctive Brivaracetam in Focal Epilepsy: Real‑World Evidence from the BRIVAracetam add‑on First Italian netwoRk Study (BRIVAFIRST)
  93. Inherited Developmental and Epileptic Encephalopathies
  94. Drugs for patients with epilepsy and excessive daytime sleepiness
  95. Neurological disorders associated with COVID-19 infection: An Italian multi-center cohort study (NEURO-COVID)
  96. Progressive supranuclear palsy: Clinical, instrumental and neuropsychological evaluation of a case in the presymptomatic phase
  97. Trigeminal neuralgia post COVID-19: Preliminary report and clinical consideration
  98. A systems‐level analysis highlights microglial activation as a modifying factor in common epilepsies
  99. Adjunctive Brivaracetam in Focal Epilepsy: Real-World Evidence from the BRIVAracetam add-on First Italian netwoRk STudy (BRIVAFIRST)
  100. Functional Gastrointestinal Disorders in Patients With Epilepsy: Reciprocal Influence and Impact on Seizure Occurrence
  101. Adjunctive Perampanel in Older Patients With Epilepsy: A Multicenter Study of Clinical Practice
  102. Letter to the editor: focal non-convulsive status epilepticus manifesting as utilization behavior
  103. Climate change and epilepsy: Insights from clinical and basic science studies
  104. Intravenous brivaracetam in status epilepticus: A multicentric retrospective study in Italy
  105. Brivaracetam as add‐on treatment in focal epilepsy: A real‐world time‐based analysis
  106. Network-based atrophy modeling in the common epilepsies: A worldwide ENIGMA study
  107. White matter abnormalities across different epilepsy syndromes in adults: an ENIGMA-Epilepsy study
  108. The ENIGMA‐Epilepsy working group: Mapping disease from large data sets
  109. Network-based atrophy modelling in the common epilepsies: a worldwide ENIGMA study
  110. Pediatric medical psychology
  111. White matter abnormalities across different epilepsy syndromes in adults: an ENIGMA Epilepsy study
  112. Epilepsy and brain channelopathies from infancy to adulthood
  113. Ultra-High-Field Targeted Imaging of Focal Cortical Dysplasia: The Intracortical Black Line Sign in Type IIb
  114. Dealing with the storm: An overview of seizure precipitants and spontaneous seizure worsening in drug-resistant epilepsy
  115. Transcranial color‐coded sonography may indirectly reveal an intracranial meningioma
  116. Acute-Onset Vertical Nystagmus and Limb Tremors in Chronic Renal Failure
  117. Italian census on neurosciences: the ICoNe2 study
  118. A systems-level analysis highlights microglial activation as a modifying factor in common forms of human epilepsy
  119. Limb Shaking Transient Ischemic Attacks with Normal Neurovascular Ultrasound may Herald Cardioembolic Stroke: A Case Report
  120. The application of artificial intelligence to understand the pathophysiological basis of psychogenic nonepileptic seizures
  121. The instruments used by the Italian centres for cognitive disorders and dementia to diagnose mild cognitive impairment (MCI)
  122. Left inferior frontal cortex can compensate the inhibitory functions of right inferior frontal cortex and pre-supplementary motor area
  123. Central Precocious Puberty in a Child With Metachromatic Leukodystrophy
  124. Structural brain abnormalities in the common epilepsies assessed in a worldwide ENIGMA study
  125. Hemicerebellitis can drive handedness shift
  126. Alexithymic trait is associated with right IFG and pre-SMA activation in non-emotional response inhibition in healthy subjects
  127. Erratum to Diffuse Brain Hypoperfusion in Advanced Leukoencephalopathy with Calcifications and Cysts
  128. Fast Progression of Cerebellar Atrophy in PLA2G6-Associated Infantile Neuronal Axonal Dystrophy
  129. Isolated recurrent myelitis in a 7-year-old child with serum aquaporin-4 IgG antibodies
  130. Immune Response to Invasive Group BStreptococcusDisease in Adults
  131. Teaching Neuro Images : Spinal cord gray matter involvement in complex I deficiency mitochondriopathy
  132. Effectiveness of 3D T2-Weighted FLAIR FSE Sequences with Fat Suppression for Detection of Brain MR Imaging Signal Changes in Children
  133. Diffuse Brain Hypoperfusion in Advanced Leukoencephalopathy with Calcifications and Cysts
  134. The syndrome of polymicrogyria, thalamic hypoplasia, and epilepsy with CSWS
  135. 7T MRI in focal epilepsy with unrevealing conventional field strength imaging
  136. Central precocious puberty due to hypothalamic hamartoma in neurofibromatosis type 1
  137. Central precocious puberty due to hypothalamic hamartoma in neurofibromatosis type 1
  138. Abnormal response to photic stimulation in Juvenile Myoclonic Epilepsy: An EEG-fMRI study
  139. Long-term retention of lacosamide in a large cohort of people with medically refractory epilepsy: A single centre evaluation
  140. Atypical face shape and genomic structural variants in epilepsy
  141. Posterior reversible encephalopathy syndrome in a complicated autoimmune background: differential diagnosis and etiological hypothesis
  142. Validation of the Italian version of the Neurological Disorders Depression Inventory for Epilepsy (NDDI-E)
  143. Incidence and management of late postsurgical seizures in clinical practice.
  144. The long-term retention of zonisamide in a large cohort of people with epilepsy at a tertiary referral centre
  145. Multicultural challenges in epilepsy
  146. Epilepsy after neuroimaging normalization in a woman with tacrolimus-related posterior reversible encephalopathy syndrome
  147. Health-related quality of life in epilepsy: Findings obtained with a new Italian instrument
  148. Incidence, risk factors and short-term mortality of stroke in Vittoria, southern Italy
  149. Oxidative stress signalling in the apoptosis of Jurkat T‐lymphocytes
  150. 424 III – VI – VII cranial nerve disorders in a patient suffering from hemorrhage in brainstem: Blink reflex and BAEP's study
  151. Regulation of the Human <i>glut4</i> Gene Expression in Tumor RD18 Cell Line